Search results: Sage Journals

Free accessResearch articleFirst published July, 2017

Annexin A2 and its downstream IL-6 and HB-EGF as secretory biomarkers in the differential diagnosis of Her-2 negative breast cancer

Praveenkumar Shetty, Vidya S Patil, Rajashekar Mohan [...]

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Open accessReview articleFirst published 2018

The Effect of Perioperative Bevacizumab on Disease-Free and Overall Survival in Locally Advanced HER-2 Negative Breast Cancer: A Meta-Analysis

Yanal Alnimer, Zakaria Hindi, Khalil Katato

Breast Cancer: Basic and Clinical Research

Restricted accessResearch articleFirst published March, 2012

The prognostic value of triple negative in stage II/III breast cancer

Afaf T Elnashar, El-Sayed M Ali, Ahmed Gaber

Journal of Oncology Pharmacy Practice

Free accessReview articleFirst published April 20, 2023

Efficacy and safety of antibody-drug conjugates in triple-negative and HER-2 positive breast cancer: A systematic review and meta-analysis of clinical trials

Fatima Afzal, Wajeeha Aiman, Hafsa Zahoor [...]

Breast Disease

Restricted accessResearch articleFirst published July, 2020

Integrated Analysis of mRNA–miRNA–lncRNA ceRNA Network in Human HR+/Her-2− Breast Cancer and Triple Negative Breast Cancer

Xiaochen Jia, Yehui Shi, Yuehong Zhu [...]

Journal of Computational Biology

Open accessResearch articleFirst published 2024

Her Lips Are Sealed: Effects of Negative Feedback on Women’s Participation in Online Political Discussions

Zhaodi Chen, Junghun Han

Socius: Sociological Research for a Dynamic World

Open accessReview articleFirst published 2013

Circulating HER2 Extracellular Domain: A Specific and Quantitative Biomarker of Prognostic Value in all Breast Cancer Patients?

Walter P. Carney, Dirk Bernhardt, Bharat Jasani

Biomarkers in Cancer

Restricted accessReview articleFirst published December, 2024

Capivasertib: A Novel AKT Inhibitor Approved for Hormone-Receptor-Positive,HER-2-Negative Metastatic Breast Cancer

Alexa J. Luboff, David L. DeRemer

Annals of Pharmacotherapy

Open accessResearch articleFirst published January, 2020

HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy

Georgios Moustakas, Spyridon Kampantais, Anastasia Nikolaidou [...]

Journal of International Medical Research

Open accessResearch articleFirst published 2019

Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer,including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial

Giuseppe Gullo, Alex J. Eustace, Alexandra Canonici [...]

Therapeutic Advances in Medical Oncology

Free accessResearch articleFirst published July, 2017

Annexin A2 and its downstream IL-6 and HB-EGF as secretory biomarkers in the differential diagnosis of Her-2 negative breast cancer

Praveenkumar Shetty, Vidya S Patil, Rajashekar Mohan [...]

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Open accessReview articleFirst published 2018

The Effect of Perioperative Bevacizumab on Disease-Free and Overall Survival in Locally Advanced HER-2 Negative Breast Cancer: A Meta-Analysis

Yanal Alnimer, Zakaria Hindi, Khalil Katato

Breast Cancer: Basic and Clinical Research

Restricted accessResearch articleFirst published March, 2012

The prognostic value of triple negative in stage II/III breast cancer

Afaf T Elnashar, El-Sayed M Ali, Ahmed Gaber

Journal of Oncology Pharmacy Practice

Free accessReview articleFirst published April 20, 2023

Efficacy and safety of antibody-drug conjugates in triple-negative and HER-2 positive breast cancer: A systematic review and meta-analysis of clinical trials

Fatima Afzal, Wajeeha Aiman, Hafsa Zahoor [...]

Breast Disease

Restricted accessResearch articleFirst published July, 2020

Integrated Analysis of mRNA–miRNA–lncRNA ceRNA Network in Human HR+/Her-2− Breast Cancer and Triple Negative Breast Cancer

Xiaochen Jia, Yehui Shi, Yuehong Zhu [...]

Journal of Computational Biology

Open accessResearch articleFirst published 2024

Her Lips Are Sealed: Effects of Negative Feedback on Women’s Participation in Online Political Discussions

Zhaodi Chen, Junghun Han

Socius: Sociological Research for a Dynamic World

Open accessReview articleFirst published 2013

Circulating HER2 Extracellular Domain: A Specific and Quantitative Biomarker of Prognostic Value in all Breast Cancer Patients?

Walter P. Carney, Dirk Bernhardt, Bharat Jasani

Biomarkers in Cancer

Restricted accessReview articleFirst published December, 2024

Capivasertib: A Novel AKT Inhibitor Approved for Hormone-Receptor-Positive,HER-2-Negative Metastatic Breast Cancer

Alexa J. Luboff, David L. DeRemer

Annals of Pharmacotherapy

Open accessResearch articleFirst published January, 2020

HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy

Georgios Moustakas, Spyridon Kampantais, Anastasia Nikolaidou [...]

Journal of International Medical Research

Open accessResearch articleFirst published 2019

Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer,including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial

Giuseppe Gullo, Alex J. Eustace, Alexandra Canonici [...]

Therapeutic Advances in Medical Oncology